NR4A1 and breast cancer: In BC hormone receptor-positive subtypes there has been detected higher levels of Ubc9 with respect to hormone receptor-negative and invasive BC lesions, and in metastatic BC, Ubc9 expression is decreased in comparison to the corresponding normal breast or primary BC (Moschos et al., 2010).